Management of Uterine Fibroids
For symptomatic uterine fibroids, treatment selection depends primarily on fibroid location and patient fertility goals: hysteroscopic myomectomy is the procedure of choice for pedunculated submucosal fibroids <5 cm, while first-line medical management with oral contraceptives or levonorgestrel IUDs should be initiated for bleeding symptoms when surgery is not immediately pursued. 1
Initial Evaluation Framework
When evaluating fibroids, focus on:
- Fibroid characteristics: Size, number, and location (submucosal, intramural, or subserosal)
- Symptom profile: Heavy menstrual bleeding, bulk symptoms (pressure, urinary frequency), or both
- Fertility desires: Current or future pregnancy plans
- Anemia status: Check hemoglobin and iron studies if bleeding is present
Medical Management Algorithm
First-Line Options
Start with these for bleeding symptoms:
- Estrogen-progestin oral contraceptive pills
- Levonorgestrel-containing IUDs
- NSAIDs for symptomatic relief
- Tranexamic acid (nonhormonal alternative for bleeding) 1
Second-Line Options
Use when first-line fails or for preoperative fibroid size reduction:
GnRH agonists (leuprolide acetate) or GnRH antagonists (elagolix, linzagolix, relugolix) significantly reduce both bleeding and tumor volume 1.
Critical caveat: As monotherapy, these cause hypoestrogenic effects (headaches, hot flushes, hypertension, bone mineral density loss). Combination treatment with low-dose estrogen and progestin is FDA-approved and mitigates these side effects 1. However, fertility is suppressed during treatment and symptoms rapidly recur after cessation 1.
Progesterone receptor modulators (ulipristal acetate) show efficacy for bleeding and bulk symptoms with intermittent dosing, but hepatotoxicity concerns prevent U.S. approval 1.
Surgical Management by Fibroid Type
Submucosal Fibroids (<5 cm)
Hysteroscopic myomectomy is the definitive choice 1. This provides:
- Shorter hospitalization than laparoscopic/open approaches
- Faster return to activities
- Equivalent quality of life improvement at 2-3 months compared to more invasive surgery 1
Important: Patients with significant intramural/subserosal burden or adenomyosis are less likely to achieve symptom relief 1.
Intramural or Subserosal Fibroids
Laparoscopic myomectomy is preferred for:
- Single or few fibroids
- Smaller uteri
- Shorter hospital stays and faster recovery than open surgery 1
Open myomectomy is indicated for:
- Multiple fibroids
- Very large uteri 1
Both approaches improve quality of life up to 10 years 1. Robotic-assisted laparoscopy shows similar outcomes to traditional laparoscopy 1.
Fertility outcomes: Less than half of patients trying to conceive achieve pregnancy after myomectomy at 3 years, and less than half of these result in live birth 1. Risk of uterine rupture in subsequent pregnancy exists 1.
Minimally Invasive Alternatives
Uterine Artery Embolization (UAE)
Appropriate for patients desiring uterus preservation who fail conservative measures. Shows 94% short-term (<12 months) and 85% long-term (>12 months) symptom improvement, with 7% requiring hysterectomy for persistent symptoms 1.
Fertility consideration: Comprehensive pregnancy data is lacking; counsel patients accordingly 1.
MR-Guided Focused Ultrasound (MRgFUS)
Uses thermal ablation without tissue damage. Complications are rare (skin burns, nerve damage, vaginal discharge) 1. Evidence shows quality of life improvement, though one randomized trial showed insignificant improvement versus placebo 1.
Laparoscopic Uterine Artery Occlusion (LUAO)
Compared to UAE: less fibroid diameter reduction (39% vs 53%) and lower complete infarction rates (23% vs 82%), but fewer post-procedural complications. Pregnancy rates are similar (67% vs 69%) 1.
Definitive Treatment
Hysterectomy remains the most common fibroid treatment in the U.S. (75% of cases) and provides definitive resolution of all symptoms 1. However, it should not be first-line for pedunculated submucosal fibroids given equally effective, less invasive options 1.
Key Clinical Pitfalls
Don't use hysteroscopic myomectomy alone for patients with significant intramural/subserosal disease or adenomyosis—they won't achieve adequate symptom relief 1
Counsel all fertility-preserving surgery patients that pregnancy is possible post-procedure, even if they state no fertility desires 1
Always use add-back therapy with GnRH agonists/antagonists to prevent hypoestrogenic complications 1
Address iron deficiency anemia before and after surgical procedures in patients with chronic bleeding 2
Endometrial ablation has no evidence base for fibroid treatment 1